These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 6539171)

  • 1. Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma.
    Whitehead RP; Rosenbaum PR; Carbone PP
    Cancer Treat Rep; 1984 May; 68(5):771-3. PubMed ID: 6539171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy in metastatic or recurrent non-small cell bronchogenic carcinoma. 5-year results.
    Ojala A; Nikkanen VN; Paloheimo S; Palojoki A; Thölix E
    Strahlentherapie; 1983 Dec; 159(12):775-7. PubMed ID: 6364459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin, cyclophosphamide, CCNU, and vincristine with or without cisplatinum in non-small cell lung cancer.
    Chlebowski RT; Chlebowski JS; Herrold J; Richardson B; Ali I; Block JB; Oktay E
    Am J Clin Oncol; 1985 Apr; 8(2):157-61. PubMed ID: 3914840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Benefits of cisplatin-based polychemotherapy in non-small cell bronchogenic carcinoma. Kyushu Lung Cancer Chemotherapy Study Group].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Tamura K; Hokama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1901-8. PubMed ID: 2454615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper hemibody and local chest irradiation as consolidation following response to high-dose induction chemotherapy for small cell bronchogenic carcinoma--a pilot study.
    Mason BA; Richter MP; Catalano RB; Creech RB
    Cancer Treat Rep; 1982 Aug; 66(8):1609-12. PubMed ID: 6286119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combination chemotherapy for bronchogenic carcinoma based on cell type].
    Ohta M; Hara N; Ichikawa Y; Kanda T; Shima K; Hokama M
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):86-94. PubMed ID: 2417564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combination chemotherapy programs in advanced adenocarcinoma-large cell carcinoma of the lung: a North Central Cancer Treatment Group study.
    Krook JE; Fleming TR; Eagan RT; Cullinan S; Pfeifle D; Elliott T; Etzell P
    Cancer Treat Rep; 1984 Mar; 68(3):493-8. PubMed ID: 6322987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophosphamide, vincristine, lomustine, cisplatin, and doxorubicin in the treatment of non-small cell lung cancer.
    Pearlman NW; Meyers TJ; Siebert PE; Wallner SF; Carson SD; Campbell DN; Johnson FB; Kennaugh R; Rempel P
    Cancer Treat Rep; 1983 Apr; 67(4):375-6. PubMed ID: 6303587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.
    Lindgren D; Cadman E; Erichson R; Grann V; Sachs K
    Cancer Treat Rep; 1984 Sep; 68(9):1159-61. PubMed ID: 6090015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: a randomized study on 70 patients.
    Xu G; Rong T; Lin P
    Chin Med J (Engl); 2000 Jul; 113(7):617-20. PubMed ID: 11776031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
    Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Lenz C
    Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for small cell bronchogenic carcinoma: CCNU and doxorubicin compared to CCNU, doxorubicin, vincristine, and procarbazine.
    Vogelzang NJ; Trowbridge RC; Frenning DH; Theologides A; Kennedy BJ; Kelly DR; Ewing SL; Vosika GJ
    Cancer Treat Rep; 1980; 64(8-9):997-1000. PubMed ID: 6256076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-intensive weekly alternating chemotherapy for patients with small cell lung cancer: randomized trial, can it improve survival of patients with good prognostic factors?
    Masutani M; Ochi Y; Kadota A; Akusawa H; Kisohara A; Takahashi N; Koya Y; Horie T
    Oncol Rep; 2000; 7(2):305-10. PubMed ID: 10671676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of hybrid administration of cyclophosphamide, doxorubicin, and vincristine (CAV)/cisplatin and etoposide (PVP) versus sequential administration of CAV-PVP for the treatment of patients with small cell lung carcinoma: results of long term follow-up.
    Ueoka H; Kiura K; Tabata M; Kamei H; Gemba K; Sakae K; Hiraki Y; Hiraki S; Segawa Y; Harada M
    Cancer; 1998 Jul; 83(2):283-90. PubMed ID: 9669811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of vindesine, etoposide, and cisplatin in patients with previously treated, advanced-stage, non-small cell bronchogenic carcinoma.
    Albain KS; Bitran JD; Golomb HM; Hoffman PC; DeMeester TR; Skosey C; Noble S; Blough RR
    Cancer Treat Rep; 1984 Feb; 68(2):413-5. PubMed ID: 6538114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
    Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.